Business Process Management

PRODUCTS

  • Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. More biologically relevant human primary cells are now the chosen starting material for immunotherapy development. Historically, scientists routinely used immortalized cell lines in the research and development of therapies as they offer an inexpensive and stable platform. However, they are not fully representative of what is going on in vivo.

  • IntegriCell™ cryopreservation services from Cryoport Systems optimize leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks. Our state-of-the-art cryopreservation process, integrated with our end-to-end global temperature-controlled supply chain platform, provides unmatched reliability, efficiency, and scope. Our standardized protocols meet the highest compliance standards, ensuring consistent quality and addressing product stability issues associated with fresh donor-derived cellular material for an optimized approach that enhances manufacturing efficiency and streamlines operations.

  • Today’s clinical researchers need precise, timely, and reliable solutions for managing huge amounts of diverse data. TrialKit AI is here to meet this demand.

  • Biotech companies progressing through clinical trials, planning an IPO, and undergoing rapid growth have a unique set of financial, contract, compliance, and reporting needs. We have designed an ERP solution, built on NetSuite, to address all of these needs. With over 50 implementations in the last two years alone, SuiteSuccess for Life Sciences is quickly becoming the defacto software standard for all successful biotechnology companies.

  • Our model combines the depth and experience level of our people with effective tools and processes already in place that are designed to ensure your critical eTMF documents and content are secure, organized, readily accessible, and always in complete compliance with all relevant regulations.

WHITE PAPERS AND CASE STUDIES

NEWS